Review Article | DOI: https://doi.org/10.31579/2834-8389/016
Medicinal Plants for the Treatment of Obesity
1Department of Eastern Medicine, Government College University Faisalabad Pakistan.
2Professor of Dental Biomaterials, College of Dentistry, Umm Alqura University, Makkah, KSA.
3Professor of Dental Biomaterials, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.
*Corresponding Author: Ibrahim M. Hamouda, Professor of Dental Biomaterials, College of Dentistry, Umm Alqura University, Makkah, KSA.
Citation: Tahreem Riaz, Muhammad Akram, Umme Laila1, Ibrahim M. Hamouda, (2024), Medicinal plants for the Treatment of Obesity, International Journal of Clinical Case Reports, 3(1); DOI:10.31579/2834-8389/016
Copyright: © 2024, Ibrahim M. Hamouda. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 01 January 2024 | Accepted: 08 February 2024 | Published: 27 February 2024
Keywords: obesity; therapeutic plants; anti-obesity mechanism; weight loss; dietary supplements
Abstract
A persistent increase in morbidity indicators has been connected to the global epidemic of obesity; it is regarded as a societal issue & poses significant health dangers. Synthetic medications and surgery are examples of therapeutic approaches; both have high prices and potentially dangerous side effects. Plant-based drugs provide an alternative strategy. Traditional uses of medicinal plants are one of the options for treating obesity, and they help with the development and research of obesity phytotherapy. In this review, we provided information regarding plant species along with their mode of action used for the effective treatment of obesity. It was revealed that the species in the catalogue had anti-obesity properties, including actions to slow down the absorption of fat, reduce enzymatic activity, mediate lipid levels, and boost the effects of lipolysis, which were primarily linked to phenolic compounds. For species with phenolic compounds in their chemical components, more thorough botanical, chemical, pre-clinical, and clinical research are especially required. The safe therapy for obesity may involve taking standardised medicinal plant extracts. The effectiveness of some plant combinations for medical purposes, however, may be reduced, and they may also have unanticipated negative effects.
Introduction
The increasing intake of high-calorie meals is the primary cause of obesity, which is regarded as a global epidemic as well as an energetic imbalance. Inactivity, environmental and social changes, particularly those affecting bargaining power and education levels, as well as the impact of others on food consumption are additional contributors [1-4]. Diabetes, osteoarthritis, dyslipidaemias, and musculoskeletal problems, including endometrial, breast, and colon cancer, are all linked to obesity [5]. Additionally, clinically apparent cardiac risk factors associated with obesity include hypertension, glucose intolerance, insulin resistance, and a high body mass index [6, 7]. Since 1980, the rates of morbidity and death have risen [8,9], making them a social issue that has attracted institutional and governmental attention [10]. Children under five who were obese numbered close to 42 million in 2013. In 2014, there were approximately than 1.9 billion overweight individuals, of whom and over 600 million were obese.
Correct diagnosis is essential to selecting the optimal course of treatment for obesity [11]. There are many integrative and complementary therapies, including diet plans, exercise, surgery, behavioural therapy, lifestyle changes, and medication-assisted treatments for hypnosis, drug addiction, acupuncture, or the utilisation of therapeutic plants [12, 13]. Because they are non-invasive, pharmacological approaches are advised for the obese person's treatment. Medications such as sibutramine, fluoxetine, sertraline, orlistat, and topiramate are among those that are advised [14]. However, since they could exacerbate the clinical picture in people with cardiovascular problems, these should be used with extreme caution.
Many people turn to alternative remedies when conventional medical treatments for chronic conditions are ineffective and ultimately dangerous. Plant-based medicines that may promote satiety, a quicker pace of weight reduction, and a higher metabolism are included in these treatments. Currently, dietary supplement-based weight loss treatments are common, indicating that ethno pharmacology & phytotherapy may be effective weight loss and preventive methods.
Plants are used medicinally because of ethno botanical and ethno pharmacological research that examines their potential for curing and preventing a wide range of illnesses. These methods draw on common knowledge, hence the conventional has grown in significance to science. Such methods also aid in the choice of study species & the creation of phototherapeutics drugs based upon ethno pharmacological research [15, 16].
In this respect, species of plants have evolved crucial for producing isolated & extract chemical components that are the basis for the creation of medicines for obesity. To ensure solid, secure, and dependable outcomes, all the factors that identify a plant as an unconventional treatment option for the treatment of illnesses must be systematically evaluated or the creation of treatment solutions, which take into consideration the cultural, social, environmental, & economic disparities between nations, evidence-based public policies, must be developed. Setting constraints for that goal and fostering knowledge exchange amongst producers, researchers, developers, and businesses are both facilitated by translational research.
Based upon the aforementioned factors, Species of plants are listed in this study which have been ethno pharmacologically mentioned as prospective remedies for obesity. These plants also possess the pharmacological potential to be turned into phototherapeutic drugs. The goal is to direct future ethno pharmacological, pre-clinical, and clinical research in the pursuit of therapeutic alternative treatments and the advancement of public health.
Anti-obesity mechanism of therapeutic plants
1. Inhibition of enzymes
Treatment for obesity has included targeting the inhibition of dietary fat breakdown and absorption. In order for triglycerides to be broken down into mono & diglycerides and smaller fatty acids that the body can absorb, it is known that the most significant enzyme, known as PL (Pancreatic Lipase), is involved. Researchers and medical professionals agree that a PL inhibitor can lessen fat breakdown, which in turn reduces fat assimilation and absorption. In obese patients, this can simulate a reduction in calorie consumption and aid in preventing further weight gain.
Due to research showing that obese people have higher levels of lipoprotein lipase (LPL), the therapy of obesity has also included targeting this enzyme. As LPL catalyses the dissolution of blood triglycerides to release free fatty acids (FFA), which increases the buildup of triglyceride in adipose tissue, suppression of LPL is envisaged to lower assimilation of FFA and assist in the control of obesity [43]. Treatment for type 2 diabetes mellitus is mostly focused on inhibiting the enzymes responsible for metabolism and digesting of carbohydrates. Because carbs make up the majority of calories consumed by humans in their meals, it could also be taken into account and relevant in study on obesity. These enzyme inhibitors reduce postprandial hyperglycemia by slowing down carbohydrate metabolism, which delays hydrolysis of glucose to triacylglycerol in adipose tissue [44].
2. Inhibition of adipogenesis
The primary energy reserve in both humans and animals is called white adipose tissue (WAT), and this is where extra energy is kept in the form of triglycerides. The equilibrium of such a process determines how well energy intake and output are balanced, which is known as metabolic homeostasis and regulates body weight. Rapid weight gain has been caused by an imbalance in energy consumption and energy expenditure. In contrast to peripheral tissues like the muscles & adipose tissue, the centralized nervous system, especially the hypothalamus, controls and coordinates energy consumption and expenditure. It has been suggested that a sophisticated network of both long- and short-term signals controls how much energy is consumed. These signals, which include neuropeptides that regulate hunger and metabolism known as orexigenic and anorexigenic neuropeptides, are absorbed by the hypothalamus [45, 46].
Triacylglycerols are recruited to make up for the shortage of energy during periods of energy restriction or hunger. One of the main causes of the predominance of obesity in the modern society is believed to be an overabundance of WAT [47]. The process of forming additional adipocytes from precursor cells, which leads to an increase in the volume of the adipocyte, is known to be involved in the expansion of adipose tissue. The development of anti-obesity-associated bioactivities has been linked to therapies that control adipocyte size and number, expression of signals related to energy balance, and inhibition or increase of particular adipokines [48].
3. Appetite suppression
In order to create long chain fatty acids from acetyl coenzyme A and malonyl-CoA, fatty acid synthase (FAS) is known to catalyse a reductive reaction. It has been demonstrated that FAS inhibition can lower food consumption & body mass in mice given FAS inhibitors. As a result, FAS inhibition is a prospective treatment goal to reduce appetite & promote lose a lot of weight [49].
Numerous plants & the compounds they produce have been demonstrated to inhibit FAS, which has a detrimental effect on appetite. Green tea's epigallocatechin gallate was discovered to be a potent inhibitor of chicken liver FAS by both irreversible slow binding and reversible quick binding. Similar to known FAS inhibitors like cerulenin and the synthetic FAS inhibitor C75, the inhibitory effects were equivalent to those of these substances [50].
Medicinal plants with anti-obesity activity
In medicine and as nutritional supplements, natural plant compounds are frequently used. Natural products are nearly as old as living itself because they have been used from the beginning of human civilization on this planet. Recent years have seen a significant increase in interest in dietary phytochemicals as potential treatments for weight loss and health enhancement. Natural compounds have long been a prolific source for the development of new medications due to their diversity in chemical composition and capacity to act on a variety of biological targets, and these drugs are used in the majority of alternative and complementary systems. Plant medicines with numerous phytochemical combinations may have a synergistic impact by acting on many biological targets, providing benefits above therapies that just use one component. The following table represent anti-obesity potential of some medicinal plants with their mechanism of action.
Medicinal Plants | Anti-obesity mechanism | References |
Green tea | It plays it mechanism by preventing the activity of pancreatic lipase | [17] |
Jasmine tea | It plays it mechanism by preventing the activity of pancreatic lipase | [18] |
Oolong tea | It plays it mechanism by preventing the activity of pancreatic lipase | [19] |
Mate tea | It plays it mechanism by preventing the activity of pancreatic lipase | [20] |
Levan | It plays it mechanism by preventing the activity of pancreatic lipase | [21] |
Chitosan | It plays it mechanism by preventing the activity of pancreatic lipase | [22] |
Soybean | It plays its anti-obesity potential by enhancing thermogenesis | [23] |
Bitter orange | It plays its anti-obesity potential by enhancing thermogenesis | [24, 25] |
Sea weed | It plays its anti-obesity potential by enhancing thermogenesis | [26, 27, 28] |
Hoodia gordonii | It plays anti-obesity mechanism by decreasing appetite | [29] |
Ginseng | It plays anti-obesity mechanism by decreasing appetite | [30] |
Pomegranate leaf | It plays anti-obesity mechanism by decreasing appetite | [31] |
Pine nut | It plays anti-obesity mechanism by decreasing appetite | [32] |
Cinnamon | It plays its anti-obesity potential by increasing the mechanism of lipids | [33] |
Herb teas | It plays its anti-obesity potential by increasing the mechanism of lipids | [34] |
Black soybean | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [35] |
Flaxseed | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [35] |
Garlic | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [36] |
Brown algae | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [37] |
Banana leaf | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [38, 39] |
Palm oil | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [40] |
Capsicum | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [41] |
Turmeric | It functions as an anti-obesity strategy by blocking adipocyte differentiation | [42] |
Table: Medicinal plants with anti-obesity mechanism
Conclusions
According to several in vivo investigations on the effectiveness of anti-obesity herbal remedies, they might work by promoting thermogenesis, reducing lipogenesis, boosting lipolysis, stifling appetite, and lowering lipid absorption. Different outcomes may result from using isolated or combined anti-obesity medicinal plant remedies. In conclusion, consuming single medicinal plants through food may be more safe and effective than consuming concoctions made from multiple medicinal plants. These results corroborate the advice of health organisations to regularly consume vegetables and particular herbs like curcumin, capsicum, ginger, & green tea. It is important to keep raising awareness of anti-obesity medication use and enticing obese people to take it, along with an improved exercise routine & a nutritious diet. Further research in the fields of chemistry, biology, and medicine is required to determine whether some medicinal plants, especially which are used as spices & condiments, can reduce and treat human obesity. Such anti-obesity information would be helpful for food & medication producers when novel goods are produced, as well as for governments in regulating food stuffs as a strategy to encourage and improve public health.
References
- Cohen-Cole E., Fletcher JM., (2008). Is obesity contagious? Social networks vs. environmental factors in the obesity epidemic. J Health Econ. 27: 1382–1387.
View at Publisher | View at Google Scholar - Hardy LL., Mihrshahi S., Gale J., Nguyen B., Baur LA., O’Hara BJ., (2015). Translational research: are community-based child obesity treatment programs scalable? BMC Public Health. 15:652.
View at Publisher | View at Google Scholar - McLaren L., (2007). Socioeconomic status and obesity. Epidemiol Rev. 29 :29–48.
View at Publisher | View at Google Scholar - Maalik A., Khan FA., Mumtaz A., Mehmood A., Azhar S., Atif M., Karim S., Altaf Y., Tariq I., (2014). Pharmacological applications of quercetin and its derivatives: a short review. Trop J Pharm Res J Cit ReportsScience Ed. 13:1561–1561.
View at Publisher | View at Google Scholar - Weir MR., (2009). The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med. 121:164–165.
View at Publisher | View at Google Scholar - Klein G., Kim J., Himmeldirk K., Cao Y., Chen X.,(2007). Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evid Based Complement Altern Med. 4:401–407.
View at Publisher | View at Google Scholar - Ogden CL., Kit BK., Fakhouri THI., Carroll MD., Flegal KM., (2014). The epidemiology of obesity among adults. GI Epidemiol Dis Clin Methodol Second Ed.394–404.
View at Publisher | View at Google Scholar - Organization WWH., (2016). No Title. Obes Overweight. 1.
View at Publisher | View at Google Scholar - Harvey JR., Ogden DE., (2014). Obesity treatment in disadvantaged population groups: where do we stand and what can we do? Prev Med (Baltim) 68:71–75.
View at Publisher | View at Google Scholar - Yanovski SZ., (2011).Obesity treatment in primary care-are we there yet? N Engl J Med. 365:2030–2031.
View at Publisher | View at Google Scholar - Dickel ML., Rates SM., Ritter MR., (2007) .Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil. J Ethnopharmacol. 109:60–71.
View at Publisher | View at Google Scholar - City INNEWY., Special Article. J Med., (2008). 346:982–987.
View at Publisher | View at Google Scholar - Apovian CM., Aronne LJ., Bessesen DH., McDonnell ME., Murad MH., Pagotto U., Ryan DH., (2015). Still CD. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 100:342–362.
View at Publisher | View at Google Scholar - Liu J., Lee J., Hernandez MAS., Mazitschek R., (2015). Ozcan U. Treatment of obesity with celastrol. Cell. 161:999–1011.
View at Publisher | View at Google Scholar - Albuquerque UP De., Hanazaki N., (2006). As pesquisas etnodirigidas na descoberta de novos fármacos de interesse médico e farmacêutico: fragilidades e pespectivas. Rev Bras Farmacogn. 16:678–689.
View at Publisher | View at Google Scholar - de Albuquerque UP., Monteiro JM., Ramos MA., de Amorim EL., (2007). Medicinal and magic plants from a public market in northeastern Brazil. J Ethnopharmacol. 110:76–91.
View at Publisher | View at Google Scholar - S. I. Koo., and S. K. Noh., (2007). Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. The Journal of Nutritional Biochemistry. 18 (3): 179-183.
View at Publisher | View at Google Scholar - H. Okuda., L. Han., Y. Kimura., (2001). et al. Anti-Obesity Action of Herb Tea.(Part 1). Effects or Various Herb Teas on Noradrenaline-Induced Lipolysis in Rat Fat Cells and Pancreatic Lipase Activity. Japanese Journal of Constitutional Medicine. 63 (1/2): 60-65.
View at Publisher | View at Google Scholar - T. Hsu., A. Kusumoto., K. Abe., (2006).et al. Polyphenol-enriched oolong tea increases fecal lipid excretion. European journal of clinical nutrition., 60 (11): 1330-1336.
View at Publisher | View at Google Scholar - F. Martins., T. M. Noso., V. B. Porto., (2009).et al. Maté tea inhibits in vitro pancreatic lipase activity and has hypolipidemic effect on high-fat diet-induced obese mice. Obesity. 18 (1): 42-47.
View at Publisher | View at Google Scholar - S. A. Kang., K. Hong., K. H. Jang., (2006). et al. Altered mRNA expression of hepatic lipogenic enzyme and PPARα in rats fed dietary levan from Zymomonas mobilis. The Journal of Nutritional Biochemistry. 17 (6): 419-426.
View at Publisher | View at Google Scholar - S. Jun., E. Jung., D. Kang.,(2010). et al. Vitamin C increases the fecal fat excretion by chitosan in guinea‐pigs, thereby reducing body weight gain. Phytotherapy Research., 24 (8): 1234-1241
View at Publisher | View at Google Scholar - K. Ishihara., S. Oyaizu., Y. Fukuchi., (2003). et al. A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice. The Journal of nutrition. 133 (3): 752-757.
View at Publisher | View at Google Scholar - S. Haaz., K. Fontaine., G. Cutter., (2006).et al. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obesity reviews., 7 (1): 79-88.A.
View at Publisher | View at Google Scholar - T. Roberts., C. K. Martin., Z. Liu., (2007). et al. The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss. Journal of medicinal food., 10 (1): 184-188.
View at Publisher | View at Google Scholar - H. Maeda., M. Hosokawa., T. Sashima., (2007). et al. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. of Agricultural and Food Chemistry., 55 (19): 7701-7706
View at Publisher | View at Google Scholar - H. Maeda., M. Hosokawa., T. Sashima., (2005).et al. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochemical and biophysical research communications., 332 (2): 392-397.
View at Publisher | View at Google Scholar - H. Maeda., T. Tsukui., T. Sashima., (2008). et al. Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient. Asia Pac J Clin Nutr., 17 (S1): 196-199.
View at Publisher | View at Google Scholar - D. E. Walsh., V. Yaghoubian., and A. Behforooz., (1984). Effect of glucomannan on obese patients: a clinical study. Int J Obes., 8 (4): 289-93
View at Publisher | View at Google Scholar - J. H. Kim., D. H. Hahm., D. C. Yang., (2005). et al. Effect of Crude Saponin of Korean Red Ginseng on High Fat DietInduced Obesity in the Rat. Journal of pharmacological sciences., 97 (1): 124-131.
View at Publisher | View at Google Scholar - F. Lei., X. N. Zhang., W. Wang., (2007). et al. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int J Obes (Lond)., 31 (6): 1023-9
View at Publisher | View at Google Scholar - W. J. Pasman., J. Heimerikx., C. M. Rubingh., (2008). et al. The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids in Health and Disease., 7 (10): 7-10
View at Publisher | View at Google Scholar - S. Smyth., and A. Heron., (2006). Diabetes and obesity: the twin epidemics. Nature Medicine., 12 (1): 75-80.
View at Publisher | View at Google Scholar - H. J. Kim., I. Y. Bae., C. W. Ahn., (2007). et al. Purification and identification of adipogenesis inhibitory peptide from black soybean protein hydrolysate. Peptides., 28 (11): 2098-2103.
View at Publisher | View at Google Scholar - J. Udani., M. Hardy., and D. C. Madsen., (2007), Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2™ brand proprietary fractionated white bean extract. Alternative medicine review., 9 (1): 63-69
View at Publisher | View at Google Scholar - S. Ambati., J. Y. Yang., S. Rayalam., (2009). et al. Ajoene exerts potent effects in 3T3‐L1 adipocytes by inhibiting adipogenesis and inducing apoptosis. Phytotherapy Research., 23 (4): 513-518.
View at Publisher | View at Google Scholar - H. Maeda., M. Hosokawa., T. Sashima., (2006). et al. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. International journal of molecular medicine., 18 (1): 147-152
View at Publisher | View at Google Scholar - N. Bai., K. He., M. Roller., (2008). et al. Active compounds from Lagerstroemia speciosa, insulin-like glucose uptakestimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. Journal of agricultural and food chemistry., 56 (24): 11668-11674
View at Publisher | View at Google Scholar - G. Klein., J. Kim., K. Himmeldirk., (2007). et al. Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evidence Based Complementary and Alternative Medicine., 4 (4): 401-408.
View at Publisher | View at Google Scholar - F. Van Heerden., (2008). Hoodia gordonii: A natural appetite suppressant. Journal of Ethnopharmacology., 119 (3): 434-437.
View at Publisher | View at Google Scholar - City INNEWY., Special Article. J Med., (2008). 346:982–987.
View at Publisher | View at Google Scholar - J. Ahn., H. Lee., S. Kim., (2007). et al. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/β-catenin signaling. American Journal of Physiology-Cell Physiology., 298 (6): C1510- C1516.
View at Publisher | View at Google Scholar - A.L. Woollett., D. C. Beitz., R. L. Hood., and S. Aprahamian., (2007 ).“An enzymatic assay for activity of lipoprotein lipase,” Analytical Biochemistry, vol. 143, no. 1, pp. 19–25,.
View at Publisher | View at Google Scholar - N. D. Yuliana., M. Jahangir., H. Korthout., Y. H. Choi., H. K. Kim., and R. Verpoorte., ? (2011).“Comprehensive review on herbal medicine for energy intake suppression,” Obesity Reviews, vol. 12, no. 7, pp. 499–514,.
View at Publisher | View at Google Scholar - S. Barcelo-Batllori., and R. Gomis., (2011). “Proteomics in obesity research,” Proteomics, vol. 3, no. 2, pp. 263–278,.
View at Publisher | View at Google Scholar - G. Morton., D. E. Cummings., D. G. Baskin., G. S. Barsh., and M. W. Schwatz.,( 1998). “Central nervous system control of food intake and body weight,” Nature, vol. 443, no. 7109, pp. 289–295, 2006.
View at Publisher | View at Google Scholar - F. M. Gregoire., C. M. Smas., and H. S. Sul., “Understanding adipocyte differentiation,” Physioligical Reviews, vol. 78, no. 3, pp. 783–809,.
View at Publisher | View at Google Scholar - S. Rayalam., M. A. Della Fera., and C. A. Baile., (2008). “Phytochemicals and regulation of the adipocyte cycle,” The Journal of Nutritional Biochemistry, vol. 19, no. 11, pp. 717–726,.
View at Publisher | View at Google Scholar - T. M. Loftus., D. E. Jaworsky., G. L. Frehywot., (2000).et al., “Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors,” Science, vol. 288, no. 5475, pp. 2379–2381,.
View at Publisher | View at Google Scholar - X. Wang., and W. Tian., (2001). “Green tea epigallocatechin gallate: a natural inhibitor of fatty acid synthase,” Biochemical and Biophysical Research Communication, vol. 28, no. 5, pp. 1200–1206,.
View at Publisher | View at Google Scholar